INCHEON, South Korea, Nov. 20, 2024 /PRNewswire/ -- Samsung Biologics (KRX: 207940.KS), a global contract development and manufacturing organization (CDMO), today announced a series of manufacturing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback